MissionIR Articles
Original content written and distributed as part of our ongoing relationships.
-
Correlate Infrastructure Partners Inc. (CIPI) Eyeing Big Net Gains Following the Enactment of the Inflation Reduction Act; Has Finalized M&A Plans Through Q2 2023 and Posted Revenue Jump
With the recently passed Inflation Reduction Act, Correlate looks to achieve significant net gains The company just posted a significant revenue bump from $236,690 in Q2 2022 to $2,313,577 in Q3 2022, plus shows project…
-
MissionIRNewsBreaks – EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQB: EVGIF) Releases Q3 2022 Earnings Report and Corporate Update, Plans Earnings Call
EverGen (TSX.V: EVGN) (OTCQB: EVGIF), Canada’s renewable natural gas (“RNG”) infrastructure platform, has released its financial results and corporate update for the three- and nine-month periods ended Sept. 30, 2022. The Q3 report milestones include…
-
BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Director of Communications and Investor Relations Presents at LD Micro Main Event
BiondVax summarizes collaboration with the prestigious Max Planck Institute for Multidisciplinary Sciences and the University Medical Center Göttingen to discover and develop nanosized antibody (NanoAb) therapies that address underserved and growing markets, including COVID-19, psoriasis,…
-
CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Announces First European Dosing in Potentially Pivotal GBM Trial
The National Brain Tumor Society anticipates that more than 13,000 Americans will receive a GBM diagnosis during 2022, accounting for 49.1% of all primary malignant brain tumors CNS announced the first patient in Europe has…
-
MissionIRNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) CEO Discusses Vast Potential of Autonomous Technology in ‘Get Authentic’ Interview
Knightscope (NASDAQ: KSCP), a developer of advanced physical security technologies focused on enhancing U.S. security operations, was featured in Get Authentic with Marques Ogden, a podcast series delivering honest, unfiltered and real-time stories from legendary…
-
MissionIRNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) Focus on Dementia and Diabetes Featured in New Interview
Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, was featured in an interview produced by PCG Digital Holdings LLC and published on NewMediaWire. John Docherty, Lexaria’s president and head of research,…
-
Vision Energy Corp. (VIHDD) Accelerates Efforts for Development of Pioneering Green Energy Terminal in North Sea Port of Vlissingen, the Netherlands
Vision Energy is in advanced stages of planning for construction and delivery of Northwestern Europe’s first import, storage and handling terminal designed exclusively for hydrogen carriers, renewable energy products and low-carbon fuels Vision Energy, through…
-
MissionIRNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Advancing Research of SPU-21 in Human Synovial Tissue
Silo Pharma (NASDAQ: SILO), a developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research, today announced its plans to initiate a pilot study of its novel joint homing peptides targeting rheumatoid arthritis…
-
MissionIRNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Schedules Q3 2022 Earnings Call
Flora (NASDAQ: FLGC), a leading all-outdoor cultivator, manufacturer and distributor of global cannabis products and brands, today announced that it will host its third quarter 2022 earnings call via webcast at 4:30 p.m. ET on…
-
HeartBeam Inc. (NASDAQ: BEAT) Awarded Top Honors for Game-Changing Cardiovascular Tech Platform
BEAT named winner of the 2022 Cardiovascular Innovations (“CVI”) Innovation Summit and Shark Tank Competition Company’s presentation included an overview of its HeartBeam AIMI™ platform, which aids in more precise heart attack diagnosis HeartBeam is…
-
Cepton, Inc. (NASDAQ: CPTN) to Solidify Its Financial Position With $100 Million Investment from Koito; Forges Ahead Toward Mass-Market Deployment of Its Lidar Technology
Cepton signed binding agreement with established automotive lighting tier 1 supplier Koito for investment of $100 million to bolster its next stage of growth Agreement penned on October 27, 2022, marks the third investment from…
-
Lexaria Bioscience Corp. (NASDAQ: LEXX) Kicks Off First-Ever Study on DehydraTECH-CBD for the Potential Treatment of Diabetes
In November 2021, Lexaria laid out its plans for several new and ongoing R&D programs, among them hormone replacement, dementia, rheumatoid disease, and diabetes The company has since begun its DIAB-A22-1 study program on the…
-
EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQX: EVGIF) is Powering a Clean Energy Future with Carbon-Negative RNG
RNG is considered carbon-neutral because it is derived from organic sources that produce methane emissions while decaying EverGen is developing Canadian RNG infrastructure with projects in British Columbia, Alberta, and Ontario EverGen’s expansion projects backed…
-
MissionIRNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) Potential Hypertension Treatment Poised to Provide Reprieve to Millions of Patients
Lexaria Bioscience Corp. (NASDAQ: LEXX) is developing a potential hypertension treatment with little to no side effects. “The treatment is created by processing cannabidiol (‘CBD’) using the company’s patented DehydraTECH(TM) drug delivery technology, which has…
-
MissionIRNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Anticipated $6M Private Placement Funding
InMed Pharmaceuticals (NASDAQ: INM), a leader in the pharmaceutical research, development and manufacturing of rare cannabinoids and cannabinoid analogs, has entered into a securities purchase agreement with two healthcare-focused institutional investors. The agreement outlines plans…
-
MissionIRNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) CEO Discusses Next-Level Technology on Stock Day Podcast
Mullen Automotive (NASDAQ: MULN), a Southern California-based company building the next generation of premium electric vehicles (“EVs”) that are affordable and built entirely in the U.S., was featured on a recent episode of the Stock…
-
MissionIRNewsBreaks – Golden Matrix Group Inc. (NASDAQ: GMGI) Announces Preliminary Fiscal 2022 Revenues, Expected 201% YOY Increase
Golden Matrix Group (NASDAQ: GMGI), a developer and licensor of gaming platforms, systems and gaming content, today announced its preliminary revenues for the fiscal year ending Oct. 31, 2022, reflecting expected record revenues of more…
-
BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Head of Technical R&D Presents Flagship NanoAbs Platform at Recent RAFT Conference
The presentation focused on BiondVax’s yeast fermentation system to manufacture innovative alpaca-derived recombinant nanosized VHH-antibodies (NanoAbs) and highlighted the company’s NanoAbs as a platform for development of therapeutics addressing diseases with large unmet medical needs…
-
Correlate Infrastructure Partners Inc. (CIPI) Sees Jump in Q3 Revenue, Big Demand for its Distributed Energy Solutions
While governmental leaders continue to work toward measurable climate progress, U.S.-based Correlate Infrastructure Partners Inc. is helping corporate clients attain ESG successes sought by investors The company recently reported that completion of construction milestones in…
-
MissionIRNewsBreaks — Cepton Inc. (NASDAQ: CPTN) Announces Next-Gen Lidar Product Honor, New Collaboration
Cepton (NASDAQ: CPTN), a Silicon Valley innovator and leader in high-performance lidar solutions, has been recognized for Vista(R)-X120 Plus, its new automotive lidar product. VistaX-120 was named a 2023 honoree in the Vehicle Tech & Advanced…
-
MissionIRNewsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) Closes on ELMS Asset with $150M Funding
Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, has received $150 million funding, which the company will use in part to close on ELMS assets. According to the announcement, the company can now…
-
MissionIRNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Accounting VP, Controller
InMed Pharmaceuticals (NASDAQ: INM), a leader in the pharmaceutical research, development and manufacturing of rare cannabinoids and cannabinoid analogs, has named Sarah Li as vice president of accounting and InMed controller; the change will be…
-
MissionIRNewsBreaks – BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) CEO Featured in The Times of Israel Article
BiondVax (NASDAQ: BVXV) is a biotechnology company focused on developing, manufacturing and commercializing innovative immunotherapeutic products primarily for the treatment of infectious diseases and autoimmune diseases. The company’s CEO Amir Reichman, as an international subject…
-
Lexaria Bioscience Corp. (NASDAQ: LEXX) Approved to Proceed with Human Study Evaluating Effectiveness of Patented DehydraTECH(TM) Technology in Boosting Oral-Tissue Absorption of Nicotine
Lexaria Bioscience recently received Independent Review Board approval for its upcoming human clinical nicotine study, NIC-H22-1, and expects to begin dosing soon The company hopes to evidence that processing purified nicotine with its patented DehydraTECH(TM)…
-
MissionIRNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) Adds Four New Client Locations, Continues Impressive Growth Expansion
Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots (“ASRs”), announced the deployment of its proprietary ASRs to four new locations. The new agreement represents the growing reach and versatility that Knightscope offers as…
-
MissionIRNewsBreaks – Tingo Inc. (TMNA), MICT Inc. (NASDAQ: MICT) Announce Tingo Mobile PLC’s Launch of Key Partnerships
Tingo (OTC: TMNA) and MICT (NASDAQ: MICT) today announced that Tingo Mobile, which is being wholly acquired by MICT with a scheduled completion date of Nov. 30, 2022, has launched its partnership with the All…
-
MissionIRNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Expands Growing Portfolio with Valuable New Patent
HeartBeam (NASDAQ: BEAT), a cardiac technology company, has developed the first and only 3D-vector electrocardiogram (“VECG”) platform for timely heart attack detection. The company today announced that the United States Patent and Trademark Office has…
-
MissionIRNewsBreaks – Freight Technologies Inc. (NASDAQ: FRGT) Featured in Chardan Report, Receives ‘Buy’ Rating
Freight Technologies (NASDAQ: FRGT), a technology company based on its custom-developed Fr8App platform, which is powered by AI and machine learning and which offers a real-time portal for B2B cross-border shipping and domestic shipping within…
-
MissionIRNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Marks Key Step in Progress Toward Commercializing Medicinal Cannabis
Flora (NASDAQ: FLGC), a leading all-outdoor cultivator, manufacturer and distributor of global cannabis products and brands, today announced the completion of its new laboratory located in Bogota, Colombia. Specializing in the manufacturing of compound formulations…
-
MissionIRNewsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) Featured in New Report Discussing Growth in EV Space
Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, is grabbing attention in the competitive electric vehicle space. A leading investor resource covering EV stocks, Investor Ideas recently released a special news report about the…
-
MissionIRNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Gains Alliance Grant Funding, Launches New Program with UBC Professor
InMed Pharmaceuticals (NASDAQ: INM), a leader in the pharmaceutical research, development and manufacturing of rare cannabinoids and cannabinoid analogs, has unveiled a new neurodegenerative disease program (“INM-900 series”). The program will focus on studying the…
-
MissionIRNewsBreaks – EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQB: EVGIF) Schedules Q3 2022 Earnings Call
EverGen (TSX.V: EVGN) (OTCQB: EVGIF), Canada’s renewable natural gas (“RNG”) infrastructure platform, has announced it will release financial numbers for its third quarter 2022 on Nov. 21, 2022, after market close. The company also plans…
-
EverGen Infrastructure Corp.’s (TSX.V: EVGN) (OTCQX: EVGIF) FVB Expansion Project Breaks Ground to Provide Lift to Company’s Revenues and EBITDA Amid a Stronger Renewable Natural Gas Market
EverGen commenced construction at its Core RNG Expansion Project at Fraser Valley Biogas; project is advancing on schedule and on budget with expected completion in Q1 2023 Expansion is estimated to double FVB’s capacity to…
-
CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) CEO Participated in The American Brain Tumor Association’s Breakthrough for Brain Tumors(R) 5K Run Following European Clinical Trial Site Activations
CNS Pharmaceuticals CEO John Climaco participated in 5K run on November 5, to show support for brain tumor patients worldwide and help raise funds for research The company recently announced European clinical trial site activations…
-
MissionIRNewsBreaks – Mullen Automotive Inc.’s (NASDAQ: MULN) ‘Strikingly Different’ EV Crossover Tour Takes the Spotlight in Vegas, Heads to Texas
Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today announced that it has successfully completed the third stop of the Mullen FIVE Strikingly Different EV Crossover Tour in Las Vegas, Nevada. According to…
-
MissionIRNewsBreaks – QSAM Biosciences Inc. (QSAM) Announces Q3 2022 Results, Provides Corporate Update
QSAM Biosciences (OTCQB: QSAM), a company developing next-generation therapeutic radiopharmaceuticals, including Samarium-153-DOTMP (CycloSam(R)), for the treatment of bone cancer and related diseases, today announced financial results for the third quarter ended Sept. 30, 2022, and…
-
MissionIRNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Announces Q2 Results, Recent Business Highlights, Presentation of CYB003 Preclinical Data at Neuroscience 2022
Cybin (NYSE American: CYBN) (NEO: CYBN), a biopharmaceutical company focused on progressing Psychedelics to Therapeutics(R), has reported unaudited financial results for its second quarter ended Sept. 30, 2022, as well as recent business highlights. “We…
-
MissionIRNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Releases Q3 2022 Financial Numbers, Corporate Update
CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, has announced its Q3 2022 financial report; the company…
-
MissionIRNewsBreaks – Freight Technologies Inc. (NASDAQ: FRGT) Focused on Improving Commerce Between US and Mexico
Freight Technologies (NASDAQ: FRGT) (“Fr8Tech”) is an over-the-road (“OTR”) shipping technology investor based in Houston, Texas. The company is focused on further improving commerce between the United States and Mexico by developing solutions that make…
Search Articles
Latest Articles
- MissionIRNewsBreaks – Newton Golf Company Inc. (NASDAQ: NWTG) Is Pushing the Boundaries of Performance in Growing Market
- Nutriband Inc. (NASDAQ: NTRB): When Regulatory Momentum Meets Leadership Continuity
- MissionIRNewsBreaks – Brera Holdings PLC (NASDAQ: BREA) Highlighted in Italian Press for Juve Stabia Player Development, Market Value Surge
- Newton Golf Company Inc. (NASDAQ: NWTG) Drives Momentum amid Record Growth in Golf Trials
- MissionIRNewsBreaks – Wearable Devices Ltd. (NASDAQ: WLDS, WLDSW) Partners With Media Exceed to Bring Neural Wearables to Japan